Clinical Trial Update: Long-Acting Progestin Contraception and the Vaginal Microbiome

View source ↗

Summary

A completed clinical trial evaluating the impact of long-acting progestin contraception on the vaginal microbiome, sponsored by Boston Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexually Transmitted Infection

Drugs mentioned

• Long-Acting Progestin Contraception

Snippet

Sponsor: Boston Medical Center | Conditions: Sexually Transmitted Infection | Status: COMPLETED